- £1.07bn
- £1.17bn
- £328.01m
- 78
- 23
- 91
- 73
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 236 | 217 | 273 | 308 | 328 |
Cost of Revenue | |||||
Gross Profit | 111 | 99.3 | 132 | 147 | 159 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 211 | 198 | 240 | 258 | 273 |
Operating Profit | 24.7 | 18.2 | 32.9 | 49.3 | 55.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 23.1 | 14.6 | 30 | 47.2 | 48.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 18.2 | 9.66 | 20.8 | 35.7 | 37.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 18.2 | 9.66 | 20.8 | 35.6 | 37.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 18.2 | 9.66 | 20.8 | 35.6 | 37.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.102 | 0.049 | 0.123 | 0.182 | 0.2 |
Dividends per Share |